322 related articles for article (PubMed ID: 37242687)
1. Phytochemicals and Cancer Treatment: Cell-Derived and Biomimetic Vesicles as Promising Carriers.
Baldassari S; Balboni A; Drava G; Donghia D; Canepa P; Ailuno G; Caviglioli G
Pharmaceutics; 2023 May; 15(5):. PubMed ID: 37242687
[TBL] [Abstract][Full Text] [Related]
2. Cell-derived biomimetic nanocarriers for targeted cancer therapy: cell membranes and extracellular vesicles.
Li A; Zhao Y; Li Y; Jiang L; Gu Y; Liu J
Drug Deliv; 2021 Dec; 28(1):1237-1255. PubMed ID: 34142930
[TBL] [Abstract][Full Text] [Related]
3. Bioinspired soft nanovesicles for site-selective cancer imaging and targeted therapies.
Prasad R; Conde J
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Jul; 14(4):e1792. PubMed ID: 35318815
[TBL] [Abstract][Full Text] [Related]
4. Lipid-hybrid cell-derived biomimetic functional materials: A state-of-the-art multifunctional weapon against tumors.
Liu WS; Wu LL; Chen CM; Zheng H; Gao J; Lu ZM; Li M
Mater Today Bio; 2023 Oct; 22():100751. PubMed ID: 37636983
[TBL] [Abstract][Full Text] [Related]
5. Biomimetic Nanovesicles-Sources, Design, Production Methods, and Applications.
Mougenot MF; Pereira VS; Costa ALR; Lancellotti M; Porcionatto MA; da Silveira JC; de la Torre LG
Pharmaceutics; 2022 Sep; 14(10):. PubMed ID: 36297442
[TBL] [Abstract][Full Text] [Related]
6. Toward the next-generation phyto-nanomedicines: cell-derived nanovesicles (CDNs) for natural product delivery.
Chen C; Wang J; Sun M; Li J; Wang HD
Biomed Pharmacother; 2022 Jan; 145():112416. PubMed ID: 34781147
[TBL] [Abstract][Full Text] [Related]
7. Research Progress in Bioinspired Drug Delivery Systems.
Tong Q; Qiu N; Ji J; Ye L; Zhai G
Expert Opin Drug Deliv; 2020 Sep; 17(9):1269-1288. PubMed ID: 32543953
[TBL] [Abstract][Full Text] [Related]
8. Recent Advances in the Development of Membrane-derived Vesicles for Cancer Immunotherapy.
Xiao Y; Wu M; Xue C; Wang Y
Curr Drug Deliv; 2024; 21(3):403-420. PubMed ID: 37143265
[TBL] [Abstract][Full Text] [Related]
9. Effective Cancer Management: Inimitable Role of Phytochemical Based Nano- Formulations.
Upaganlawar A; Polshettiwar S; Raut S; Tagalpallewar A; Pande V
Curr Drug Metab; 2022; 23(11):869-881. PubMed ID: 36065928
[TBL] [Abstract][Full Text] [Related]
10. Macrophage-Derived Extracellular Vesicles as Drug Delivery Systems for Triple Negative Breast Cancer (TNBC) Therapy.
Haney MJ; Zhao Y; Jin YS; Li SM; Bago JR; Klyachko NL; Kabanov AV; Batrakova EV
J Neuroimmune Pharmacol; 2020 Sep; 15(3):487-500. PubMed ID: 31722094
[TBL] [Abstract][Full Text] [Related]
11. Membrane Derived Vesicles as Biomimetic Carriers for Targeted Drug Delivery System.
Zhang LY; Yang X; Wang SB; Chen H; Pan HY; Hu ZM
Curr Top Med Chem; 2020; 20(27):2472-2492. PubMed ID: 32962615
[TBL] [Abstract][Full Text] [Related]
12. Plant-derived nanovesicles: Further exploration of biomedical function and application potential.
Li A; Li D; Gu Y; Liu R; Tang X; Zhao Y; Qi F; Wei J; Liu J
Acta Pharm Sin B; 2023 Aug; 13(8):3300-3320. PubMed ID: 37655320
[TBL] [Abstract][Full Text] [Related]
13. Extracellular vesicles as natural therapeutic agents and innate drug delivery systems for cancer treatment: Recent advances, current obstacles, and challenges for clinical translation.
Pirisinu M; Pham TC; Zhang DX; Hong TN; Nguyen LT; Le MT
Semin Cancer Biol; 2022 May; 80():340-355. PubMed ID: 32977006
[TBL] [Abstract][Full Text] [Related]
14. Stem cell membrane, stem cell-derived exosomes and hybrid stem cell camouflaged nanoparticles: A promising biomimetic nanoplatforms for cancer theranostics.
Khosravi N; Pishavar E; Baradaran B; Oroojalian F; Mokhtarzadeh A
J Control Release; 2022 Aug; 348():706-722. PubMed ID: 35732250
[TBL] [Abstract][Full Text] [Related]
15. Advances on erythrocyte-mimicking nanovehicles to overcome barriers in biological microenvironments.
Castro F; Martins C; Silveira MJ; Moura RP; Pereira CL; Sarmento B
Adv Drug Deliv Rev; 2021 Mar; 170():312-339. PubMed ID: 32946921
[TBL] [Abstract][Full Text] [Related]
16. Extracellular vesicles: Novel promising delivery systems for therapy of brain diseases.
Rufino-Ramos D; Albuquerque PR; Carmona V; Perfeito R; Nobre RJ; Pereira de Almeida L
J Control Release; 2017 Sep; 262():247-258. PubMed ID: 28687495
[TBL] [Abstract][Full Text] [Related]
17. Plant-Derived Extracellular Vesicles as Therapeutic Nanocarriers.
Karamanidou T; Tsouknidas A
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008617
[TBL] [Abstract][Full Text] [Related]
18. Biomimetic Boron Nitride Nanoparticles for Targeted Drug Delivery and Enhanced Antitumor Activity.
Li H; Qiao W; Shen Y; Xu H; Fan Y; Liu Y; Lan Y; Gong Y; Chen F; Feng S
Pharmaceutics; 2023 Apr; 15(4):. PubMed ID: 37111754
[TBL] [Abstract][Full Text] [Related]
19. Biomimetic and bioinspired nanoparticles for targeted drug delivery.
Gagliardi M
Ther Deliv; 2017 Mar; 8(5):289-299. PubMed ID: 28361608
[TBL] [Abstract][Full Text] [Related]
20. Bioinspired and Biomimetic Nanomedicines.
Chen Z; Wang Z; Gu Z
Acc Chem Res; 2019 May; 52(5):1255-1264. PubMed ID: 30977635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
